Approval · Notice of Compliance 4090 · 1997
INTRALIPID: Notice of Compliance 4090
Issued November 17, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4090
- Date
- November 17, 1997
- Company
- Pharmacia & Upjohn Inc.Mississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Fat emulsions for intravenous nutrition
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INTRALIPID | 02065681 | Dormant |
| INTRALIPID | 02065673 | Marketed |
| INTRALIPID | 02216175 | Dormant |
Medicinal ingredients
- SOYBEAN OIL 10 G per 100ML
- EGG PHOSPHOLIPIDS 1.2 G per 100ML
- GLYCERINE 2.2 G per 100ML
- SOYBEAN OIL 20 G per 100ML
- SOYBEAN OIL 30 G per 100ML
- GLYCERINE 1.67 G per 100ML